The emerging role of citrate as a diagnostic biomarker in SLC13A5 ‐developmental and epileptic encephalopathy

Documenti analoghi

• Late infantile epileptic encephalopathy: A distinct developmental and epileptic encephalopathy syndrome
  di: Shawn Kacker, et al.
  Pubblicazione: (2024)
• Expanding the phenotypic spectrum of CACNA1A ‐related developmental and epileptic encephalopathy in adults
  di: Orazio Palumbo, et al.
  Pubblicazione: (2026)
• Monozygotic twins with ZMYND11 ‐related developmental and epileptic encephalopathy with spike‐and‐wave activation in sleep
  di: Matias Juanes, et al.
  Pubblicazione: (2026)
• A retrospective study of the yield of next‐generation sequencing in the diagnosis of developmental and epileptic encephalopathies and epileptic encephalopathies in 0–12 years aged children at a single tertiary care hospital in South India
  di: Manasa C. Murthy, et al.
  Pubblicazione: (2024)
• UBA5 ‐epileptic encephalopathy: new patient, a novel variant, and a review of epileptic phenotypes
  di: C. Cinnirella, et al.
  Pubblicazione: (2025)